SG10201912354PA - Humanized il-4 and il-4r alpha animals - Google Patents

Humanized il-4 and il-4r alpha animals

Info

Publication number
SG10201912354PA
SG10201912354PA SG10201912354PA SG10201912354PA SG10201912354PA SG 10201912354P A SG10201912354P A SG 10201912354PA SG 10201912354P A SG10201912354P A SG 10201912354PA SG 10201912354P A SG10201912354P A SG 10201912354PA SG 10201912354P A SG10201912354P A SG 10201912354PA
Authority
SG
Singapore
Prior art keywords
humanized
animals
alpha
alpha animals
Prior art date
Application number
SG10201912354PA
Other languages
English (en)
Inventor
Li-Hsien Wang
Yingzi Xue
Andrew J Murphy
Sean Stevens
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG10201912354PA publication Critical patent/SG10201912354PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG10201912354PA 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals SG10201912354PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461989757P 2014-05-07 2014-05-07

Publications (1)

Publication Number Publication Date
SG10201912354PA true SG10201912354PA (en) 2020-02-27

Family

ID=53284509

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201608570YA SG11201608570YA (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals
SG10201912354PA SG10201912354PA (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201608570YA SG11201608570YA (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals

Country Status (26)

Country Link
US (7) US9565841B2 (enrdf_load_html_response)
EP (3) EP3027015B1 (enrdf_load_html_response)
JP (5) JP6640740B2 (enrdf_load_html_response)
KR (2) KR102473565B1 (enrdf_load_html_response)
CN (2) CN110269047B (enrdf_load_html_response)
AU (3) AU2015255977B2 (enrdf_load_html_response)
BR (1) BR112016025745A2 (enrdf_load_html_response)
CA (2) CA3207834A1 (enrdf_load_html_response)
CY (2) CY1119773T1 (enrdf_load_html_response)
DK (2) DK3027015T3 (enrdf_load_html_response)
ES (2) ES2887852T3 (enrdf_load_html_response)
HR (2) HRP20180242T1 (enrdf_load_html_response)
HU (2) HUE038028T2 (enrdf_load_html_response)
IL (3) IL248358B2 (enrdf_load_html_response)
LT (2) LT3027015T (enrdf_load_html_response)
MX (1) MX370672B (enrdf_load_html_response)
NO (1) NO2785538T3 (enrdf_load_html_response)
PH (1) PH12016502058A1 (enrdf_load_html_response)
PL (2) PL3281521T3 (enrdf_load_html_response)
PT (2) PT3281521T (enrdf_load_html_response)
RS (2) RS62345B1 (enrdf_load_html_response)
RU (1) RU2703139C2 (enrdf_load_html_response)
SG (2) SG11201608570YA (enrdf_load_html_response)
SI (2) SI3281521T1 (enrdf_load_html_response)
SM (2) SMT202100560T1 (enrdf_load_html_response)
WO (1) WO2015171861A1 (enrdf_load_html_response)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2785538T3 (enrdf_load_html_response) 2014-05-07 2018-08-04
RU2735958C2 (ru) 2014-06-19 2020-11-11 Регенерон Фармасьютикалз, Инк. Животные, отличные от человека, имеющие гуманизированный ген 1 запрограммированной гибели клеток
ES2946664T3 (es) * 2014-09-17 2023-07-24 Oerlikon Surface Solutions Ag Pfaeffikon Método para producir una herramienta de corte con recubrimiento de doble capa con resistencia mejorada al desgaste
SG11201703800PA (en) 2014-11-24 2017-06-29 Regeneron Pharma Non-human animals expressing humanized cd3 complex
LT3086637T (lt) 2014-12-05 2019-04-10 Regeneron Pharmaceuticals, Inc. Gyvūnai, išskyrus žmogų, turintys humanizuota diferenciacijos klasterio 47 geną
PL3808775T3 (pl) 2014-12-09 2024-08-19 Regeneron Pharmaceuticals, Inc. Inne niż ludzie zwierzęta mające humanizowany gen klastra różnicowania 274
BR112018010158A2 (pt) 2015-11-20 2018-11-21 Regeneron Pharma roedor, polipeptídeo lag-3 humanizado, célula ou tecido, célula-tronco embrionária e embrião de roedor, métodos para produzir um roedor, para avaliar a eficácia antitumoral e as propriedades farmacocinéticas de uma droga
CN108779159B (zh) 2016-02-04 2022-12-30 瑞泽恩制药公司 具有经改造的angptl8基因的非人动物
CA3014645C (en) 2016-02-29 2022-10-25 Regeneron Pharmaceuticals, Inc. Rodents having a humanized tmprss gene
TWI784988B (zh) * 2016-12-01 2022-12-01 美商再生元醫藥公司 治療發炎症狀的方法
KR102605045B1 (ko) 2017-04-13 2023-11-27 리제너론 파마슈티칼스 인코포레이티드 Il33 및 il1rl1을 코딩하는 유전자에서의 위험 대립유전자를 갖는 환자에서의 폐 질환의 치료 및 저해
CN110997725B (zh) 2017-06-12 2024-08-09 蓝鳍生物医药公司 抗-il1rap抗体和抗体药物缀合物
MX394999B (es) 2017-09-29 2025-03-24 Regeneron Pharma Animales no humanos que comprenden un locus ttr humanizado y metodos de uso
AU2018375796B2 (en) 2017-11-30 2024-11-21 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized TRKB locus
MA52177A (fr) 2018-03-26 2021-02-17 Regeneron Pharma Rongeurs humanisés pour tester des agents thérapeutiques
IL307286A (en) 2018-04-11 2023-11-01 Regeneron Pharma Methods and preparations for quantification of IL-33
JP7048051B2 (ja) 2018-07-11 2022-04-05 正徳 染井 痒みを軽減するアトピー性皮膚炎治療剤
PT3823443T (pt) 2018-07-16 2024-07-29 Regeneron Pharma Modelos de roedores da-doença ditra e as suas utilizações
WO2020074005A1 (en) * 2018-10-12 2020-04-16 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric genes
WO2020147829A1 (zh) * 2019-01-17 2020-07-23 北京百奥赛图基因生物技术有限公司 人源化转基因动物
CN117178959A (zh) 2019-04-04 2023-12-08 瑞泽恩制药公司 包括人源化凝血因子12基因座的非人动物
CA3137761A1 (en) 2019-06-04 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
EP3796776A1 (en) 2019-06-07 2021-03-31 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized albumin locus
WO2021018198A1 (en) * 2019-07-29 2021-02-04 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric il33
US20220312749A1 (en) * 2019-08-09 2022-10-06 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric il2ra
CN112779285B (zh) * 2019-11-11 2023-01-06 百奥赛图(北京)医药科技股份有限公司 人源化il-10和il-10ra基因改造动物的构建方法和应用
WO2021129766A1 (zh) * 2019-12-25 2021-07-01 江苏集萃药康生物科技股份有限公司 一种il-15人源化小鼠模型及其用途
CN115175559A (zh) * 2020-01-28 2022-10-11 瑞泽恩制药公司 包含人源化pnpla3基因座的非人动物及其使用方法
CN111149767B (zh) * 2020-02-24 2021-07-20 中南大学湘雅二医院 一种人源化皮肤型红斑狼疮小鼠模型的构建方法和应用
CN113527485B (zh) 2020-04-17 2024-11-15 湖南麦济生物技术股份有限公司 抗人白细胞介素-4受体α抗体及其制备方法和应用
CN111808882B (zh) * 2020-09-01 2020-12-29 北京百奥赛图基因生物技术有限公司 Il7r基因人源化改造的动物模型的构建方法及其应用
CN111793646B (zh) * 2020-09-08 2021-01-15 北京百奥赛图基因生物技术有限公司 Il1r1基因人源化改造的非人动物的构建方法及其应用
CN111926039B (zh) * 2020-09-23 2021-03-16 百奥赛图(北京)医药科技股份有限公司 Il-13基因人源化的非人动物的构建方法和应用
IL303724A (en) * 2020-12-21 2023-08-01 Regeneron Pharma Non-human animals having a humanized tslp gene, a humanized tslp receptor gene, and/or a humanized il7ra gene
CN114835798B (zh) * 2021-05-28 2024-02-23 百奥赛图(北京)医药科技股份有限公司 Cd36基因人源化非人动物的构建方法及应用
CN120035675A (zh) * 2022-09-28 2025-05-23 百奥赛图(北京)医药科技股份有限公司 一种il5和/或il5ra基因人源化修饰的非人动物
CN120569783A (zh) * 2023-01-11 2025-08-29 瑞泽恩制药公司 用于符合规定的自动化测定的系统和方法
WO2025175099A1 (en) 2024-02-16 2025-08-21 Regeneron Pharmaceuticals, Inc. A rodent copd model

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005183A1 (en) * 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
DK1802193T3 (da) 2004-10-19 2014-06-10 Regeneron Pharma Fremgangsmåde til frembringelse af en homozygot mus til genetisk modifikation
JP2007252370A (ja) * 2006-02-22 2007-10-04 Institute Of Physical & Chemical Research Ｉｌ−４初期発現系トランスジェニック非ヒト動物およびその利用
US7608693B2 (en) 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
US20110016543A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genomic editing of genes involved in inflammation
SG176118A1 (en) * 2009-06-29 2011-12-29 Qingfeng Chen Methods of producing humanized non-human mammals
JP2013500018A (ja) * 2009-07-24 2013-01-07 シグマ−アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニー ゲノム編集のための方法
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
AU2010303737B2 (en) 2009-10-06 2014-05-29 Institute For Research In Biomedicine (Irb) Genetically modified mice and engraftment
KR102256316B1 (ko) * 2011-02-15 2021-05-28 리제너론 파마슈티칼스 인코포레이티드 인간화된 ｍ－ｃｓｆ 마우스
LT3590332T (lt) 2011-10-28 2022-08-10 Regeneron Pharmaceuticals, Inc. Genetiškai modifikuotos pelės, ekspresuojančios chimerines pagrindinio audinių dermės komplekso (mhc) ii molekules
JP6154391B2 (ja) 2011-10-28 2017-06-28 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 遺伝子改変された主要組織適合複合体マウス
WO2013063556A1 (en) * 2011-10-28 2013-05-02 Regeneron Pharmaceuticals, Inc. Humanized il-6 and il-6 receptor
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
SI2888281T1 (sl) * 2012-08-21 2019-03-29 Sanofi Biotechnology Postopki zdravljenja ali preventive astme z administracijo antagonista IL-4R
EP4606818A2 (en) 2012-09-07 2025-08-27 Yale University Methods of using genetically modified mice
KR102768101B1 (ko) 2012-11-05 2025-02-18 리제너론 파마슈티칼스 인코포레이티드 유전자 변형된 비-인간 동물 및 그것의 사용 방법
US9848587B2 (en) 2013-02-20 2017-12-26 Regeneron Pharmaceuticals, Inc. Humanized T cell co-receptor mice
AU2014218893C1 (en) 2013-02-22 2019-03-07 Regeneron Pharmaceuticals, Inc. Mice expressing humanized Major Histocompatibility Complex
JO3532B1 (ar) 2013-03-13 2020-07-05 Regeneron Pharma الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
SMT202500280T1 (it) 2013-09-23 2025-09-12 Regeneron Pharma Animali non umani aventi un gene umanizzato della proteina regolatrice del segnale
LT3138397T (lt) 2013-10-15 2019-04-10 Regeneron Pharmaceuticals, Inc. Humanizuoti il-15 gyvūnai
ES2703549T3 (es) 2013-11-19 2019-03-11 Regeneron Pharma Animales no humanos que tienen un gen de un ligando inductor de la proliferación humanizado
JP6505689B2 (ja) 2013-11-19 2019-04-24 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． ヒト化ｂ細胞活性化因子遺伝子を有する非ヒト動物
SG10201908800YA (en) 2014-04-08 2019-11-28 Regeneron Pharma Non-human animals having humanized fc-gamma receptors
BR112016025751A2 (pt) 2014-05-05 2018-01-16 Regeneron Pharma roedor, e, métodos para fabricar um roedor e um camundongo humanizados e para identificar um composto capaz de modular a ativação de complemento
NO2785538T3 (enrdf_load_html_response) 2014-05-07 2018-08-04

Also Published As

Publication number Publication date
DK3027015T3 (en) 2018-01-22
JP6640740B2 (ja) 2020-02-05
RU2703139C2 (ru) 2019-10-15
SG11201608570YA (en) 2016-11-29
CY1119773T1 (el) 2018-06-27
IL297105A (en) 2022-12-01
RU2019131253A (ru) 2019-12-06
HRP20211455T1 (hr) 2022-01-07
JP7145250B2 (ja) 2022-09-30
SMT202100560T1 (it) 2021-11-12
DK3281521T3 (da) 2021-09-20
IL248358B2 (en) 2023-03-01
RS62345B1 (sr) 2021-10-29
CA2947307C (en) 2023-09-26
IL248358A0 (en) 2016-11-30
PT3281521T (pt) 2021-09-16
AU2015255977A1 (en) 2016-11-17
AU2021218060A1 (en) 2021-09-09
IL297105B1 (en) 2023-09-01
US10477842B2 (en) 2019-11-19
PH12016502058A1 (en) 2017-01-09
EP3281521A1 (en) 2018-02-14
JP2020058379A (ja) 2020-04-16
US20150320022A1 (en) 2015-11-12
LT3281521T (lt) 2021-09-27
KR20220165814A (ko) 2022-12-15
US9565841B2 (en) 2017-02-14
RU2016143376A3 (enrdf_load_html_response) 2018-11-22
US20180000056A1 (en) 2018-01-04
KR102473565B1 (ko) 2022-12-02
CY1124605T1 (el) 2022-07-22
HUE055860T2 (hu) 2021-12-28
IL297105B2 (en) 2024-01-01
CN110269047B (zh) 2021-11-02
JP2021087434A (ja) 2021-06-10
BR112016025745A2 (pt) 2018-01-16
ES2887852T3 (es) 2021-12-28
US9743647B2 (en) 2017-08-29
ES2656529T3 (es) 2018-02-27
JP2017514501A (ja) 2017-06-08
PL3027015T3 (pl) 2018-04-30
PT3027015T (pt) 2018-02-09
EP3906781A1 (en) 2021-11-10
AU2024204694A1 (en) 2024-09-05
US20170311580A1 (en) 2017-11-02
US20200022344A1 (en) 2020-01-23
IL248358B (en) 2022-11-01
JP2024159985A (ja) 2024-11-08
MX370672B (es) 2019-12-19
MX2016014563A (es) 2017-02-23
LT3027015T (lt) 2018-01-25
HRP20180242T1 (hr) 2018-03-09
NO2785538T3 (enrdf_load_html_response) 2018-08-04
US20150320021A1 (en) 2015-11-12
US12310340B2 (en) 2025-05-27
HUE038028T2 (hu) 2018-09-28
SMT201800018T1 (it) 2018-03-08
US11109578B2 (en) 2021-09-07
RS57073B1 (sr) 2018-06-29
KR20160150637A (ko) 2016-12-30
CA2947307A1 (en) 2015-11-12
NZ725615A (en) 2024-05-31
NZ763861A (en) 2024-05-31
EP3281521B1 (en) 2021-06-30
US20230027494A1 (en) 2023-01-26
AU2021218060C1 (en) 2024-11-07
SI3281521T1 (sl) 2021-11-30
JP6838131B2 (ja) 2021-03-03
CA3207834A1 (en) 2015-11-12
RU2016143376A (ru) 2018-06-09
WO2015171861A1 (en) 2015-11-12
IL304841B1 (en) 2025-09-01
KR102517112B1 (ko) 2023-04-03
EP3027015A1 (en) 2016-06-08
EP3027015B1 (en) 2017-11-08
US20210368753A1 (en) 2021-12-02
CN106470545A (zh) 2017-03-01
AU2021218060B2 (en) 2024-04-11
AU2015255977B2 (en) 2021-09-02
CN110269047A (zh) 2019-09-24
JP2022171841A (ja) 2022-11-11
US11963521B2 (en) 2024-04-23
CN106470545B (zh) 2019-08-20
IL304841A (en) 2023-09-01
US10588298B2 (en) 2020-03-17
SI3027015T1 (en) 2018-02-28
PL3281521T3 (pl) 2022-01-03

Similar Documents

Publication Publication Date Title
IL297105B1 (en) Animals with il–4 and il–4r alpha of human origin
IL276946A (en) Antiproliferative compounds and methods of use
IL248481B (en) Animals containing c5 and c3 of human origin
IL252216B (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
IL252929A0 (en) Anti-acth antibodies from humans and their use
GB201401617D0 (en) Novel combination and use
IL247315B (en) Anti-acth antibodies and their uses
HUE052575T2 (hu) Új kombináció és alkalmazás
IL251335A0 (en) Piperidinylpyrazolopyrimidinones and their use
GB201420805D0 (en) Ligatures and use thereof
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie